These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 33963461)

  • 1. Organic Cation Transporter Expression and Function in the CNS.
    Sweet DH
    Handb Exp Pharmacol; 2021; 266():41-80. PubMed ID: 33963461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and function of organic cation and anion transporters (SLC22 family) in the CNS.
    Farthing CA; Sweet DH
    Curr Pharm Des; 2014; 20(10):1472-86. PubMed ID: 23789957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Region-specific blood-brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer's disease.
    Sekhar GN; Fleckney AL; Boyanova ST; Rupawala H; Lo R; Wang H; Farag DB; Rahman KM; Broadstock M; Reeves S; Thomas SA
    Fluids Barriers CNS; 2019 Dec; 16(1):38. PubMed ID: 31842924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organic Cation Transporter (OCT/OCTN) Expression at Brain Barrier Sites: Focus on CNS Drug Delivery.
    Betterton RD; Davis TP; Ronaldson PT
    Handb Exp Pharmacol; 2021; 266():301-328. PubMed ID: 33674914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live Tissue Imaging Reveals Distinct Transcellular Pathways for Organic Cations and Anions at the Blood-Cerebrospinal Fluid Barrier.
    Hu T; Zha W; Sun A; Wang J
    Mol Pharmacol; 2022 May; 101(5):334-342. PubMed ID: 35193935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of organic anion/cation transporters at the blood-brain and blood-cerebrospinal fluid barriers involving uremic toxins.
    Hosoya K; Tachikawa M
    Clin Exp Nephrol; 2011 Aug; 15(4):478-85. PubMed ID: 21611756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abundant Expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1, and xCT Transporters in Blood-Arachnoid Barrier of Pig and Polarized Localizations at CSF- and Blood-Facing Plasma Membranes.
    Uchida Y; Goto R; Takeuchi H; Łuczak M; Usui T; Tachikawa M; Terasaki T
    Drug Metab Dispos; 2020 Feb; 48(2):135-145. PubMed ID: 31771948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family.
    Dos Santos Pereira JN; Tadjerpisheh S; Abu Abed M; Saadatmand AR; Weksler B; Romero IA; Couraud PO; Brockmöller J; Tzvetkov MV
    AAPS J; 2014 Nov; 16(6):1247-58. PubMed ID: 25155823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane transporter proteins: a challenge for CNS drug development.
    Girardin F
    Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The blood-brain barrier choline transporter.
    Geldenhuys WJ; Allen DD
    Cent Nerv Syst Agents Med Chem; 2012 Jun; 12(2):95-9. PubMed ID: 22483271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organic cation transporter 1 (OCT1) is involved in pentamidine transport at the human and mouse blood-brain barrier (BBB).
    Sekhar GN; Georgian AR; Sanderson L; Vizcay-Barrena G; Brown RC; Muresan P; Fleck RA; Thomas SA
    PLoS One; 2017; 12(3):e0173474. PubMed ID: 28362799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inner Blood-Retinal Barrier Dominantly Expresses Breast Cancer Resistance Protein: Comparative Quantitative Targeted Absolute Proteomics Study of CNS Barriers in Pig.
    Zhang Z; Uchida Y; Hirano S; Ando D; Kubo Y; Auriola S; Akanuma SI; Hosoya KI; Urtti A; Terasaki T; Tachikawa M
    Mol Pharm; 2017 Nov; 14(11):3729-3738. PubMed ID: 28954515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug transporters at brain barriers: expression and regulation by neurological disorders.
    Ashraf T; Kis O; Banerjee N; Bendayan R
    Adv Exp Med Biol; 2012; 763():20-69. PubMed ID: 23397618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrates and Inhibitors of Organic Cation Transporters (OCTs) and Plasma Membrane Monoamine Transporter (PMAT) and Therapeutic Implications.
    Bönisch H
    Handb Exp Pharmacol; 2021; 266():119-167. PubMed ID: 34495395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General Overview of Organic Cation Transporters in Brain.
    Koepsell H
    Handb Exp Pharmacol; 2021; 266():1-39. PubMed ID: 33782773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of Carrier-Mediated Transport at the Blood-Cerebrospinal Fluid Barrier in Spermine Clearance from Rat Brain.
    Akanuma SI; Shimada H; Kubo Y; Hosoya KI
    Biol Pharm Bull; 2017; 40(9):1599-1603. PubMed ID: 28867747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cationic drug-sensitive transport systems at the blood-cerebrospinal fluid barrier in para-tyramine elimination from rat brain.
    Akanuma SI; Yamazaki Y; Kubo Y; Hosoya KI
    Fluids Barriers CNS; 2018 Jan; 15(1):1. PubMed ID: 29307307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organic Cation Transporters in Human Physiology, Pharmacology, and Toxicology.
    Samodelov SL; Kullak-Ublick GA; Gai Z; Visentin M
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats.
    Zhang Z; Tachikawa M; Uchida Y; Terasaki T
    Mol Pharm; 2018 Mar; 15(3):911-922. PubMed ID: 29436232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLC22, SLC44, and SLC47 transporters--organic anion and cation transporters: molecular and cellular properties.
    Pelis RM; Wright SH
    Curr Top Membr; 2014; 73():233-61. PubMed ID: 24745985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.